Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;71(9):736-743.
doi: 10.1097/MAT.0000000000002402. Epub 2025 Feb 20.

The Impact of Preoperative Right Ventricular Dysfunction and Ventricular Arrhythmias on Left Ventricular Assist Device Outcomes

Douglas Hall  1 , Rahul A Chhana  2 , Bin Q Yang  3 , Elena Deych  1 , Christopher T Sparrow  4 , Praveen Rao  2 , Michael E Nassif  5 , Shane J LaRue  6 , Joel D Schilling  1
Affiliations

The Impact of Preoperative Right Ventricular Dysfunction and Ventricular Arrhythmias on Left Ventricular Assist Device Outcomes

Douglas Hall et al. ASAIO J. .

Abstract

Ventricular arrhythmias (VA) are common in patients being evaluated for left ventricular assist devices (LVADs) but the impact of comorbid right ventricular dysfunction (RVD) on outcomes after LVAD is not known. We performed a single-center, retrospective cohort study of patients undergoing LVAD implantation from 2005 to 2021. Patients were stratified by VA history before LVAD into no VA, low burden VA (LBVA), or clinically significant VA (CSVA) groups. Right ventricular function was assessed by baseline echo. Time-to-event analyses were used with a primary outcome of all-cause mortality. Secondary outcomes were implantable cardioverter-defibrillator (ICD) shock, rehospitalization, and postoperative complications related to RV failure. A total of 761 patients were included, of which 442 (58%) had no VA, 120 (16%) had LBVA, and 199 (26%) had CSVA. The mean age was 57 and 584 (77%) of patients were male. Within the CSVA group, mortality was higher in those with baseline RVD (hazard ratio [HR] = 1.6, confidence interval [CI] = 1.1-2.5). Clinically significant VA and renal dysfunction were associated with mortality on Cox proportional hazards modeling. Implantable cardioverter-defibrillator shocks after LVAD were more common in those with LBVA or CSVA. There was no difference in 6-month rehospitalization between groups. Patients with a history of CSVA undergoing LVAD implantation are at increased risk for mortality and this risk is predominantly seen in those with comorbid RVD.

Keywords: LVAD; arrhythmias; cardiac; heart failure; heart-assist devices; right ventricular dysfunction.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

References

    1. Peura JL, Colvin-Adams M, Francis GS, et al.; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology: Recommendations for the use of mechanical circulatory support: Device strategies and patient selection: A scientific statement from the American Heart Association. Circulation. 126: 2648–2667, 2012.
    1. Mehra MR, Uriel N, Naka Y, et al.; MOMENTUM 3 Investigators: A fully magnetically levitated left ventricular assist device—Final report. N Engl J Med. 380: 1618–1627, 2019.
    1. Numan L, Schramm R, Oerlemans MIFJ, et al.: Survival after HeartMate 3 left ventricular assist device implantation: Real‐world data from Europe. ESC Heart Fail. 10: 2754–2756, 2023.
    1. Yuan N, Arnaoutakis GJ, George TJ, et al.: The spectrum of complications following left ventricular assist device placement. J Card Surg. 27: 630–638, 2012.
    1. Greet BD, Pujara D, Burkland D, et al.: Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. JACC Clin Electrophysiol. 4: 257–264, 2018.

LinkOut - more resources